Cytek Biosciences, Inc.

NASDAQ:CTKB

5.06 (USD) • At close September 18, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -12.1482.4843.02719.411-16.827
Depreciation & Amortization 9.235.6591.2420.6030.309
Deferred Income Tax 4.8300.4481.7440
Stock Based Compensation 22.04816.5956.5860.6110.269
Change In Working Capital -10.509-39.928-8.646-7.5361.158
Accounts Receivables -7.332-19.744-12.3670.334-12.612
Inventory 4.286-17.653-7.068-5.704-14.614
Accounts Payables -1.7841.862-0.256-0.0551.213
Other Working Capital -5.679-4.39311.045-2.11127.171
Other Non Cash Items -8.172.9591.9730.3231.344
Operating Cash Flow 5.281-12.2314.6315.156-13.747
Investing Activities:
Investments In Property Plant And Equipment -4.827-9.868-4.364-1.547-0.973
Acquisitions Net -45.1320-16.62900
Purchases Of Investments -175.935-46.041000
Sales Maturities Of Investments 1320000
Other Investing Activites -44.114-46.1610.37100
Investing Cash Flow -93.894-55.909-20.993-1.547-0.973
Financing Activities:
Debt Repayment -0.565-0.05-2.772-1.310
Common Stock Issued 1.4681.204215.689119.8350.093
Common Stock Repurchased -44.151-0.209000
Dividends Paid 00000
Other Financing Activities 2.9044.7770.6424.0820.093
Financing Cash Flow -41.8125.513213.559122.6070.093
Other Information:
Effect Of Forex Changes On Cash -1.445-2.4911.303-0.587-0.033
Net Change In Cash -131.87-65.118198.499135.629-14.66
Cash At End Of Period 167.63299.5364.618166.11930.49